Galectin Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $440k | 209k | 2.11 |
| 2024-12-31 | $374k | 290k | 1.29 |
| 2024-09-30 | $677k | 246k | 2.75 |
| 2024-06-30 | $514k | 227k | 2.26 |
| 2024-03-31 | $441k | 185k | 2.39 |
| 2023-12-31 | $307k | 185k | 1.66 |
| 2023-09-30 | $355k | 185k | 1.92 |
| 2023-06-30 | $266k | 185k | 1.44 |
| 2022-12-31 | $39k | 39k | 1.00 |
| 2022-06-30 | $77k | 59k | 1.30 |
| 2022-03-31 | $96k | 64k | 1.51 |
| 2021-06-30 | $120k | 41k | 2.95 |
| 2020-12-31 | $121k | 54k | 2.25 |
| 2020-09-30 | $87k | 32k | 2.76 |
| 2020-06-30 | $199k | 65k | 3.05 |
| 2020-03-31 | $110k | 56k | 1.99 |
| 2019-12-31 | $468k | 164k | 2.86 |
| 2019-09-30 | $283k | 77k | 3.66 |
| 2019-03-31 | $299k | 59k | 5.07 |
| 2018-12-31 | $213k | 62k | 3.43 |
| 2018-09-30 | $342k | 58k | 5.92 |
| 2018-06-30 | $391k | 61k | 6.37 |
| 2018-03-31 | $210k | 44k | 4.75 |
| 2017-12-31 | $53k | 16k | 3.30 |
| 2017-03-31 | $206k | 90k | 2.30 |
| 2016-12-31 | $6.7k | 6.5k | 1.03 |
| 2016-09-30 | $6.3k | 6.6k | 0.95 |
| 2016-06-30 | $11k | 8.1k | 1.35 |
| 2016-03-31 | $0 | 5.9k | 0.00 |
| 2015-12-31 | $15k | 11k | 1.47 |
| 2015-09-30 | $34k | 14k | 2.39 |
| 2015-06-30 | $74k | 27k | 2.71 |
| 2014-12-31 | $346k | 100k | 3.45 |
| 2014-09-30 | $130k | 26k | 5.01 |
| 2014-06-30 | $1.2M | 85k | 13.83 |
| 2014-03-31 | $1.4M | 92k | 15.30 |
| 2013-12-31 | $149k | 18k | 8.42 |
| 2013-09-30 | $146k | 15k | 9.96 |